Amylx Pharmaceuticals Inc vs PAGSEG Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while PAGSEG Inc trades at $8.87 (market cap $2.48B). The key difference: Amylx Pharmaceuticals Inc and PAGSEG Inc are close in size by market cap, and PAGSEG Inc pays a 11.7% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | PAGS | |
|---|---|---|
Market Cap | $2.64B | $2.48B |
Sector | Health | Technology |
52-Week High | $24.19 | $12.00 |
52-Week Low | $7.82 | $8.38 |
Enterprise Value | $2.39B | $10.22B |
Dividend Yield | — | 11.7% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →